LEUCOVORIN CALCIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Leucovorin Calcium, and what generic alternatives are available?
Leucovorin Calcium is a drug marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Hainan Poly, Hikma, Meitheal, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, Fresenius Kabi Usa, Novast Labs, Ani Pharms, Barr, Epic Pharma Llc, Leading, Par Pharm, Xanodyne Pharm, Am Regent, Mylan Labs Ltd, Sagent Pharms, and Sagent Pharms Inc. and is included in forty-eight NDAs.
The generic ingredient in LEUCOVORIN CALCIUM is leucovorin calcium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Leucovorin Calcium
A generic version of LEUCOVORIN CALCIUM was approved as leucovorin calcium by HIKMA on September 14th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEUCOVORIN CALCIUM?
- What are the global sales for LEUCOVORIN CALCIUM?
- What is Average Wholesale Price for LEUCOVORIN CALCIUM?
Summary for LEUCOVORIN CALCIUM
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 48 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 63 |
| Clinical Trials: | 477 |
| Patent Applications: | 5,445 |
| Drug Prices: | Drug price information for LEUCOVORIN CALCIUM |
| DailyMed Link: | LEUCOVORIN CALCIUM at DailyMed |
Recent Clinical Trials for LEUCOVORIN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fudan University | Phase 3 |
| Arcus Biosciences, Inc. | Phase 1/Phase 2 |
| Jonsson Comprehensive Cancer Center | Phase 1/Phase 2 |
Pharmacology for LEUCOVORIN CALCIUM
| Drug Class | Folate Analog |
Medical Subject Heading (MeSH) Categories for LEUCOVORIN CALCIUM
US Patents and Regulatory Information for LEUCOVORIN CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 040147-001 | Jun 25, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 072736-001 | Feb 22, 1993 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Barr | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 071198-001 | Sep 24, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novast Labs | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 211132-004 | Jul 30, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 040056-001 | May 23, 1995 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
